Log in to save to my catalogue

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698158

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells

About this item

Full title

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14305

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Trabectedin is used for the treatment of advanced soft tissue sarcomas (STSs). In this study, we evaluated if trabectedin could enhance the efficacy of irradiation (IR) by increasing the intrinsic cell radiosensitivity and modulating tumor micro-environment in fibrosarcoma (HS 93.T), leiomyosarcoma (HS5.T), liposarcoma (SW872), and rhabdomyosarcoma...

Alternative Titles

Full title

Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698158

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698158

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms232214305

How to access this item